Delivery Order SPE2DB20D2104-SPE2DB25FMZQD
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $2,387.01 to AmerisourceBergen Drug Corp for Annovera vaginal rings. This is a firm fixed-price, competitively awarded contract with a completion date of September 23, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,570.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.12 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded contract represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,810.98 to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,637.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 25, 2025, with completion expected by July 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order totaling $1,377.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on June 2, 2025, with completion expected by June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings, valued at $8,469.84 under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.03 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed-price contract. This non-set-aside award was issued on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $3,014.46 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Annovera vaginal rings. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award carries no set-aside designation and will...
- The Defense Logistics Agency awarded a delivery order valued at $1,375.23 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for federal...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZQDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,954.22 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medical products to support military and veteran healthcare systems. The company's extensive portfolio with the Defense Logistics Agency includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Annovera vaginal rings reflects the company's ongoing role in providing pharmaceutical products through the DLA's global pharmaceutical support network, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 9/5/25 |